Edition:
United Kingdom

Cytori Therapeutics Inc (CYTX.OQ)

CYTX.OQ on NASDAQ Stock Exchange Capital Market

0.24USD
22 Mar 2019
Change (% chg)

$-0.02 (-7.52%)
Prev Close
$0.26
Open
$0.25
Day's High
$0.25
Day's Low
$0.24
Volume
208,382
Avg. Vol
119,346
52-wk High
$3.30
52-wk Low
$0.22

Latest Key Developments (Source: Significant Developments)

Cytori Files Pre-Submission Request For New Drug Application
Thursday, 7 Mar 2019 

March 7 (Reuters) - Cytori Therapeutics Inc ::CYTORI FILES PRE-SUBMISSION REQUEST FOR NEW DRUG APPLICATION.CYTORI THERAPEUTICS - FILED FORMAL NDA PRE-SUBMISSION REQUEST TO EMA FOR DOXORUBICIN HYDROCHLORIDE CYTORI.CYTORI THERAPEUTICS INC - EXPECTS TO RECEIVE ASSIGNMENT OF A RAPPORTEUR AND CO-RAPPORTEUR BY END OF APRIL.CYTORI THERAPEUTICS INC - MAA SUBMISSION IS PLANNED FOR LATER IN 2019 OR EARLY 2020..  Full Article

Cytori Therapeutics Says Co Entered Into Amendment To Existing Loan And Security Agreement Dated May 29, 2015
Tuesday, 5 Mar 2019 

March 5 (Reuters) - Cytori Therapeutics Inc ::CYTORI THERAPEUTICS SAYS ON MARCH 4, 2019, CO ENTERED INTO AMENDMENT TO EXISTING LOAN AND SECURITY AGREEMENT, DATED MAY 29, 2015 - SEC FILING.  Full Article

Cytori Therapeutics Says Co Entered Into An Amendment To Its Existing Loan And Security Agreement, Dated May 29, 2015
Wednesday, 2 Jan 2019 

Jan 2 (Reuters) - Cytori Therapeutics Inc ::CYTORI THERAPEUTICS SAYS ON DEC. 31, ENTERED INTO AN AMENDMENT TO ITS EXISTING LOAN AND SECURITY AGREEMENT, DATED MAY 29, 2015 - SEC FILING.CYTORI THERAPEUTICS INC - AS PER AMENDMENT OXFORD AND LENDERS AGREED TO EXTEND MATURITY DATE FROM JUNE 1, 2019 TO JUNE 1, 2020.CYTORI THERAPEUTICS INC - AMENDMENT ALSO INCREASES MINIMUM LIQUIDITY COVENANT LEVEL FROM $1.5 MILLION TO $2.0 MILLION.CYTORI THERAPEUTICS INC - AMENDMENT EXTENDS INTEREST-ONLY PERIOD UNDER LOAN AGREEMENT TO MARCH 1, 2019.  Full Article

Cytori Therapeutics Files Prospectus Relates To Offer, Sale Of Co's Stock
Friday, 21 Sep 2018 

Sept 21 (Reuters) - Cytori Therapeutics Inc ::CYTORI THERAPEUTICS FILES PROSPECTUS RELATES TO OFFER, SALE OF UP TO 3.7 MILLION SHARES OF CO'S COMMON STOCK BY LINCOLN PARK CAPITAL FUND LLC - SEC FILING.  Full Article

Cytori Therapeutics Enters Agreement With B. Riley FBR To Sell Its Shares
Friday, 1 Jun 2018 

June 1 (Reuters) - Cytori Therapeutics Inc ::CYTORI THERAPEUTICS INC - ON JUNE 1, ENTERED SALES AGREEMENT WITH B. RILEY FBR TO SELL ITS SHARES WITH AGGREGATE OFFERING PRICE OF UP TO $6.5 MILLION.  Full Article

Swissquote Bank SA Reports 12 pct Passive Stake In Cytori Therapeutics As Of Dec. 29, 2017
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Cytori Therapeutics Inc ::SWISSQUOTE BANK SA REPORTS 12 PERCENT PASSIVE STAKE IN CYTORI THERAPEUTICS INC AS OF DECEMBER 29, 2017 - SEC FILING‍​.  Full Article

Cytori Therapeutics Inc ‍announces new investigator initiated U.S. clinical trial for hip osteonecrosis​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Cytori Therapeutics Inc :Cytori Therapeutics Inc - ‍announced a new investigator initiated U.S. clinical trial for hip osteonecrosis​.  Full Article

Cytori reports Q3 loss per share $0.14
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Cytori Therapeutics Inc :Cytori reports third quarter 2017 business and financial results.Q3 loss per share $0.14.Cytori Therapeutics Inc - ‍received U.S. FDA IDE approval for relief, a thermal burn pilot trial related to ongoing barda contract​.Cytori Therapeutics Inc - ‍expects full year 2017 operating cash burn to be lower than 2016, primarily due to restructuring announced in September 2017​.  Full Article